---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-23-000030"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T10:54:32.731389+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CV Sciences Q2 revenue $4.0M; gross margin 43.3%, operating loss narrows to $1.1M

## Summary
- Revenue of $4.0M, down 4% YoY from $4.1M; units sold down 16%, offset by higher average selling price.
- Gross margin improved to 43.3% vs 30.7% YoY; operating loss narrowed to $1.1M from $2.3M.
- Cash balance $1.7M at quarter-end vs $0.6M at FY2022; generated $2.4M cash from operations in H1 2023 (incl. $2.5M ERC).
- Extinguished outstanding note payable; evaluating strategic options including merger or sale.
- Maintained #1 hemp extract brand in natural product retail channel; launched PlusCBD Reserve Collection Extra Gummies.

## SEC filing metadata
- accession: 0001510964-23-000030
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/0001510964-23-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/cvsi-20230814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-23-000030
- JSON: https://secwatch.observer/filing/0001510964-23-000030.json
- Plain text: https://secwatch.observer/filing/0001510964-23-000030.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the quarter ended June 30, 2023 results: revenue $4.0 million.
  - Period: the quarter ended June 30, 2023
  - Revenue: $4.0 million
  - Result: reported results
  source text: and products, today announced its financial results for the quarter ended June 30, 2023. Second Quarter 2023 and Recent Financial and Operating Highlights • Generated revenue of $4.0 million for the second quarter 2023 compared to $4.1 million for second quarter 2022; • Recognized gross margin of 43.3% for the second quarter 2023 compared to 30.7% for the second
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000030/0001510964-23-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.